Oxford researchers part of major UK initiative to understand chronic pain
13 May 2022
Reproductive Medicine & Genetics
Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.
Dawes-Redman Education awarded funds from Huntleigh Healthcare
12 May 2022
The Dawes-Redman Education programme which offers virtual CTG Analysis training sessions to Obstetric consultants, antenatal and student midwifes has received generous funds from Huntleigh Healthcare for the next 3 years.
AIMDay in Women's Health 2022 - Read the Blogs
10 May 2022
On 22nd March 2022, The University of Oxford hosted an AIMday in Women's Health at St Anne's College in Oxford. The key objective was to match the needs of organisations for new knowledge with academic expertise, with the ultimate goal of improving healthcare diagnoses & treatments for women and reproductive health.
Endometriosis: pandemic backlog risks making it even harder for women to get help
27 April 2022
Reproductive Medicine & Genetics
The COVID-19 pandemic has had a disproportionate and devastating impact on women’s health, according to a report from the Royal College of Obstetricians and Gynaecologists.
Diagnostic test could offer new hope for ME/CFS patients
13 April 2022
Reproductive Medicine & Genetics
Myalgic Encephalomyelitis /Chronic Fatigue Syndrome (ME/CFS) is a chronic condition without a diagnostic test and some 80 - 90% of patients remain un-diagnosed. A new paper published in Frontiers in Medicine outlines how having a diagnostic test could greatly help both patients and medics.
The link between childhood risk factors and adult cardiovascular events revealed
6 April 2022
A new international study published April 4th 2022, in The New England Journal of Medicine finds, for the first time, direct evidence that the recognised risk factors for cardiovascular disease when present in childhood, predict the risk of adult cardiovascular events such as myocardial infarction and stroke.
First UK pilot study of newborn screening for spinal muscular atrophy (SMA) launched in Oxford
1 April 2022
Spinal muscular atrophy (SMA) is a rare, but treatable, genetic disease affecting approximately 1 in 10,000 births, and it typically presents in infancy and early childhood.
Professor Collins awarded Sir Jules Thorn Translational Biomedical Research Award 2021
3 March 2022
Professor Sally Collins has been awarded the prestigious and highly competitive Sir Jules Thorn Translational Biomedical Research Award 2021 for further translational development of the OxNNet Toolkit.
Global INTERCOVID-2022 Study launched to compare Covid-19 during pregnancy, with pregnant women without the infection.
15 February 2022
Global Health Maternal & Fetal Health
The Oxford Maternal & Perinatal Health Institute (OMPHI) has launched the 2022 round of the global study to evaluate the effects of Covid-19 variants and vaccination in pregnancy.
MitOX 2022- 8th April
14 February 2022
Reproductive Medicine & Genetics
The Nuffield Department of Women's & Reproductive Health invites you to MitOX 2022 on Friday 8th April. Our annual conference for researchers with an interest in mitochondria from academia and pharma. This year's event will be 'hybrid', so you can join in-person or virtually!
New guidelines launched for diagnosis and management of Endometriosis
2 February 2022
Reproductive Medicine & Genetics
A new comprehensive document by the European Society of Human Reproduction and Embryology (ESHRE) outlines more than 100 recommendations on best practice on caring for women with Endometriosis.
Endometriosis podcast - listen now!
20 December 2021
Reproductive Medicine & Genetics
In this latest podcast episode, our DPhil students Danielle Perro and Magda Mareckova, explore how surgery, psychological interventions, and other more holistic and personalised options can help manage endometriosis associated symptoms.
New Professor title awarded
20 December 2021
Our department is celebrating a new WRH Professor! Congratulations to Prof Dagan Wells, who is awarded the full Professor title from the University of Oxford, in their annual Recognition of Distinction Exercise.
Blood pressure drugs could protect against type 2 diabetes
18 November 2021
Lowering high blood pressure is an effective way to reduce a person’s risk of developing type 2 diabetes in the future.
AIMday in Women's Health - 22nd March 2022
22 October 2021
The University of Oxford will be hosting an AIMday in Women’s Health on Tuesday 22nd March 2022 at St Anne's College in Oxford. This event will bring together academic excellence from across the University of Oxford together with industry to help answer the most pressing challenges in this area, as identified by industry.
Menopause Workplace Pledge
18 October 2021
We are pleased to share that the Nuffield Department of Women's & Reproductive Health has signed the Menopause Workplace Pledge. This is a new campaign by Wellbeing of Women that calls on organisations to commit to recognising that the menopause is a workplace issue, and that women need support, as well as talking respectfully and openly about the menopause, and actively supporting and informing colleagues.
Researchers identify genetic cause of endometriosis and potential drug target
31 August 2021
Reproductive Medicine & Genetics
Endometriosis is a painful, chronic condition in which tissue from the uterus inappropriately grows outside the uterus.
Success with the Pfizer Maternal C-19 Vaccine Trial
23 July 2021
Congratulations to Prof. Manu Vatish and the OSPREA-Gynae team on recruiting their first participant to the Pfizer maternal C-19 vaccine trial on 22nd July.
First woman in UK receives dose of therapeutic HPV vaccine
5 July 2021
NDWRH and Vaccitech Ltd, a clinical-stage biopharmaceutical company engaged in the discovery and development of vaccines for the treatment and prevention of infectious diseases and cancer, see the first woman in the UK receive the first dose of a novel therapeutic HPV vaccine for the HPV001 clinical trial in Oxford.
First trimester placental scan - Artificial Intelligence in Health and Care Award
17 June 2021
A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.
Vision for Women’s Health Strategy for England
A vision document on a strategy for women’s health in England has been published by the Department of Health and Social Care after nearly 100,000 women came forward to share their healthcare experiences. The document sets out initial government commitments on women’s health, recognising that system-wide changes are needed to tackle “decades of gender health inequality”. The final plan - the Women’s Health Strategy will be published in the spring.
